Immunome, Inc. is a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class cancer therapies, including ADCs, gamma secretase inhibitors, radiotherapy, and other targeted solid tumor programs. The posting is a proactive resume submission notice rather than an active requisition, asking candidates to submit their resume for future consideration and to monitor the career page for matching openings.
Every query opens live roles, salary samples, and market demand — tap a search to run it instantly.
Unlock powerful job search, personalized recommendations, and deep career insights from comprehensive, market-leading data and live market signals.
For job seekers
Upload your résumé, start a Job Search Thread, and let Metaintro rank real openings against your experience — then guide you from search to offer.
Match
Compare live roles against your current evidence.
Position
Turn proof projects into role-specific applications.
Improve
Use market feedback to keep the skill plan current.
oncology
Immunome is a clinical-stage oncology company developing antibody-drug conjugates and other targeted therapies to improve outcomes for cancer patients. It discovers and develops differentiated targeted cancer therapies addressing high unmet need, with a mission to advance and expand a portfolio of therapeutic candidates. Its pipeline includes late-clinical-stage varegacestat, Phase 1 IM-1021, IM-3050, which received IND clearance in Q1 2025, and preclinical ADC programs. Its team members have played key roles in designing, developing, and commercializing treatments, including ADCs that are now standard-of-care for multiple cancer indications.
Who they serve
Immunome develops therapies for cancer patients.